These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33390543)

  • 1. Protective Effect of Edaravone against Cationic Lipid-Mediated Oxidative Stress and Apoptosis.
    Terada T; Kulkarni JA; Huynh A; Tam YYC; Cullis P
    Biol Pharm Bull; 2021; 44(1):144-149. PubMed ID: 33390543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edaravone, a cytoprotective drug, enhances transgene expression mediated by lipoplexes in HepG2 cells and mice.
    Wang S; Fumoto S; Miyamoto H; Tanaka M; Nishida K
    Int J Pharm; 2018 Sep; 548(1):173-181. PubMed ID: 29969708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
    Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
    J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
    Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
    Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.
    Dokka S; Toledo D; Shi X; Castranova V; Rojanasakul Y
    Pharm Res; 2000 May; 17(5):521-5. PubMed ID: 10888302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.
    Homma T; Kobayashi S; Sato H; Fujii J
    Exp Cell Res; 2019 Nov; 384(1):111592. PubMed ID: 31479686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of edaravone against cisplatin-induced chronic renal injury.
    Koike N; Sasaki A; Murakami T; Suzuki K
    Drug Chem Toxicol; 2021 Jul; 44(4):437-446. PubMed ID: 31064223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
    Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
    Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edaravone attenuates cadmium-induced toxicity by inhibiting oxidative stress and inflammation in ICR mice.
    Fan SR; Ren TT; Yun MY; Lan R; Qin XY
    Neurotoxicology; 2021 Sep; 86():1-9. PubMed ID: 34174317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cargo-Free Nanoparticles Containing Cationic Lipids Induce Reactive Oxygen Species and Cell Death in HepG2 Cells.
    Yun CH; Bae CS; Ahn T
    Biol Pharm Bull; 2016; 39(8):1338-46. PubMed ID: 27476941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone ameliorates compression-induced damage in rat nucleus pulposus cells.
    Lin H; Ma X; Wang BC; Zhao L; Liu JX; Pu FF; Hu YQ; Hu HZ; Shao ZW
    Life Sci; 2017 Nov; 189():76-83. PubMed ID: 28942283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Edaravone against hypoxia-induced cytotoxicity in osteoblasts MC3T3-E1 cells.
    Cao B; Chai C; Zhao S
    IUBMB Life; 2015 Dec; 67(12):928-33. PubMed ID: 26596678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients.
    Park JM; Kim SY; Park D; Park JS
    Neurol Sci; 2020 Jan; 41(1):119-123. PubMed ID: 31471712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia.
    Banno M; Mizuno T; Kato H; Zhang G; Kawanokuchi J; Wang J; Kuno R; Jin S; Takeuchi H; Suzumura A
    Neuropharmacology; 2005 Feb; 48(2):283-90. PubMed ID: 15695167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone prevents high glucose-induced injury in retinal Müller cells through thioredoxin1 and the PGC-1α/NRF1/TFAM pathway.
    Yin J; Chen X
    Pharm Biol; 2021 Dec; 59(1):1233-1244. PubMed ID: 34506218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of cationic liposomes composed of cationic lipid YKS-220 having an ester linkage: adequate stability, high transfection efficiency, and low cytotoxicity.
    Obika S; Yu W; Shimoyama A; Uneda T; Minami T; Miyashita K; Doi T; Imanishi T
    Biol Pharm Bull; 1999 Feb; 22(2):187-90. PubMed ID: 10077439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells.
    Yan Y; Gong K; Ma T; Zhang L; Zhao N; Zhang X; Tang P; Gong Y
    Neurosci Lett; 2012 Dec; 531(2):160-5. PubMed ID: 23127846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress.
    Jami MS; Salehi-Najafabadi Z; Ahmadinejad F; Hoedt E; Chaleshtori MH; Ghatrehsamani M; Neubert TA; Larsen JP; Møller SG
    Neurochem Int; 2015 Nov; 90():134-41. PubMed ID: 26232623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice.
    Shimazaki H; Hironaka K; Fujisawa T; Tsuruma K; Tozuka Y; Shimazawa M; Takeuchi H; Hara H
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7289-97. PubMed ID: 21849425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.